Predictors of early discontinuation of chemotherapy (EDC) in patients (pts) age 65 or older with stage IV non-small cell lung cancer (NSCLC).
Ajeet Gajra
No relevant relationships to disclose
William P. Tew
No relevant relationships to disclose
Molly Hardt
No relevant relationships to disclose
Supriya Gupta Mohile
No relevant relationships to disclose
Cynthia Owusu
No relevant relationships to disclose
Heidi D. Klepin
No relevant relationships to disclose
Cary P. Gross
No relevant relationships to disclose
Stuart M. Lichtman
No relevant relationships to disclose
Vani Katheria
No relevant relationships to disclose
Arti Hurria
Consultant or Advisory Role - Amgen; Genentech; GTx
Research Funding - Abraxis BioScience; Celgene; GlaxoSmithKline